Anomaly: Sapporo Clinical Lab (9776.T JPX) JPY 330,696,128 Feb 2026: verify vol
The 9776.T stock shows a striking intraday price anomaly at JPY 330,696,128.00 on 26 Feb 2026, forcing traders to check data feeds and liquidity. This intraday piece examines why the quoted price and zero printed volume conflict with average activity and historic ranges. We compare the spike to fundamentals, technical signals, Meyka AI forecasts, and give concrete price targets and trading cautions for JPX-listed Sapporo Clinical Laboratory Inc.
Intraday snapshot: 9776.T stock price and volume
Price printed at JPY 330,696,128.00 with volume 0 on the JPX intraday tape. The previous close was JPY 1,960.00, and the 52-week high shows JPY 351,364,640.00 while the 52-week low is JPY 1,942.00.
This disconnect—massive price delta and zero reported volume—suggests a data feed error, post-trade correction, or corporate action misquote rather than ordinary high-volume buying. Traders should verify with official JPX notices and order book data before placing trades.
Why the spike may be a data or corporate event
No public corporate release explains an intraday gap to JPY 330,696,128.00 on 26 Feb 2026. The company website lists routine services and no headline M&A or split source.
Given the avgVolume 5,361.00 shares and no reported trade size, the likely causes are a reporting glitch, a fat-finger order, or an unprocessed corporate action. We advise checking JPX notice boards and brokers for trade confirmations source.
Fundamentals and valuation: what the books show for 9776.T stock
Sapporo Clinical Laboratory Inc. (9776.T, JPX, Japan) reports solid balance-sheet metrics: market cap JPY 6,087,895,648.00, price/book 0.53, and price/sales 0.30. Trailing measures include P/E 15.74 and dividend per share JPY 23.00.
Meyka AI rates 9776.T with a score out of 100: 69.33 (Grade B, Suggestion: HOLD). This grade factors S&P 500 and sector comparison, financial growth, key metrics, forecasts, and analyst signals. These fundamentals contrast sharply with the intraday quote and point to a valuation anchored near the low thousands of JPY rather than hundreds of millions.
Technicals, liquidity and high-volume movers context
Technical indicators show extremes: RSI 100.00 and a large MACD histogram, consistent with a one-off spike rather than sustainable trend. Average price over 50 days stands at JPY 332,214,080.00 and 200-day at JPY 237,153,344.00, but those averages reflect the same anomalous prints.
True liquidity is low: avgVolume 5,361.00 shares and on-book depth is likely thin. For a high-volume movers strategy, this stock carries elevated execution risk. Use limit orders and confirm fills with brokers.
Analyst view and price targets for 9776.T stock
There is no public consensus price target available for 9776.T. Based on fundamentals and recent results, a reasoned short-term target range is JPY 1,800.00–JPY 2,200.00 and a 12-month fair-value target near JPY 1,114.67 from model projections.
Meyka AI’s forecast model projects a 12-month price of JPY 1,114.67. Forecasts are model-based projections and not guarantees.
Trading strategy, risks and monitoring steps
If you trade 9776.T stock intraday, treat the current quote as suspect until trade confirmations arrive. Use small sizes, limit orders, and post-trade verification. Watch for JPX trade halts or correction notices.
Primary risks are data errors, low liquidity, and price-quote anomalies. Opportunities exist only when confirmed trades show real demand at sensible price levels near book-value metrics.
Final Thoughts
The 9776.T stock print at JPY 330,696,128.00 on 26 Feb 2026 is best read as an anomalous quote until JPX or brokers confirm an executed trade. Fundamentals for Sapporo Clinical Laboratory Inc. point to modest valuation metrics—P/E 15.74, P/B 0.53, and market cap JPY 6,087,895,648.00—that do not support the intraday figure. Meyka AI’s forecast model projects a 12-month price of JPY 1,114.67, implying a model-based downside of approximately -99.99% versus the quoted intraday price; forecasts are model-based projections and not guarantees. Given the thin average volume (5,361.00 shares), traders should verify the tape, avoid large market orders, and treat confirmed prints near the low thousands of JPY as the actionable range. Meyka AI provides this piece as an AI-powered market analysis platform to help confirm data and shape risk-aware trades.
FAQs
Why does the 9776.T stock show such a large intraday price?
The large intraday price likely reflects a data feed error, fat-finger order, or an unprocessed corporate action. Confirm with JPX notices and broker trade confirmations before acting.
What is Meyka AI’s view on 9776.T stock valuation?
Meyka AI rates 9776.T at 69.33/100 (Grade B, HOLD). Fundamentals point to fair value near JPY 1,114.67 over 12 months from model projections, not the intraday anomaly.
How should traders approach intraday orders in 9776.T stock?
Use limit orders, trade small sizes, and verify execution reports. Low average volume (5,361.00) raises execution risk, so avoid large market orders until the tape is confirmed.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.